Gold Flora Corporation

Gold Flora reported Q3 2024 revenue of $32.6 million, up 3% from $31.6 million in Q2. Gross profit was $13.5 million, up 86% quarter over quarter, with gross margin at 41% versus 23% in Q2. Adjusted gross profit was $21.1 million with a 65% adjusted gross margin, compared with $18.2 million and 57% in Q2. Net loss improved to $18.9 million from $24 million in Q2, and adjusted EBITDA returned to positive $2.8 million from a $2 million loss. Cash and cash equivalents were $10.2 million at September 30, 2024. Looking ahead, management said it expects continued positive adjusted EBITDA growth, some natural softness at the end of the year, ongoing revenue growth from Gramlin, additional product launches, and Q4 cost cuts including about a 10% payroll reduction. The company also expects the additional 53,000 square feet of cultivation canopy to come online in 2025 once licenses are obtained.

Laurie Holcomb framed the quarter as proof that Gold Flora’s vertical integration and investment cycle are starting to pay off. She emphasized operational optimization, stronger harvest yields, and Gramlin’s rapid brand growth as evidence that the company is gaining momentum despite a contracting cannabis market. Her tone was confident and expansionary, with a stated goal of building toward top-tier California scale and broader brand rollout in 2025.

Marshall Minor focused on the improving financial profile: revenue of $32.6 million, gross profit of $13.5 million at 41% margin, adjusted gross profit of $21.1 million at 65%, and adjusted EBITDA of $2.8 million. He said the improvement came from more first-party brand sales, especially Gramlin, plus cultivation efficiencies and cost reductions. On liquidity and capital structure, he noted $10.2 million of cash at quarter-end, the $13.15 million JJ Astor loan facility, and the expectation of $10 million to $14 million in potential 280E tax refunds, while confirming the company is filing as a normal corporation going forward.

Analysts pressed on whether positive adjusted EBITDA can continue, and management said it believes adjusted EBITDA growth should continue, with only modest normal year-end softness. Questions also focused on pricing; management said indoor flower pricing and demand have increased recently, while retail CPG pricing is more promotional and basket sizes are slightly down. On growth and capacity, management said wholesale sales are rising month over month, repurchase rates are strong, and there is still additional capacity in the existing facility before the new canopy comes online in 2025.